Less than $10/month! Screen on your Watchlists and Portfolios with Barchart Plus. FREE 30 Day Trial
or

Arcturus Therapeutics Ltd (ARCT)

Arcturus Therapeutics Ltd (ARCT)
12.07 -0.70 (-5.48%) 13:08 ET [NASDAQ]
12.00 x 6 12.11 x 6
Realtime by (Cboe BZX)
12.00 x 6 12.11 x 6
Realtime 12.56 -0.21 (-1.64%) 06:49 ET
Quote Overview for Wed, Mar 26th, 2025
Watch
    Add or delete the symbol from one or more Watchlists.
Day Low
12.14
Day High
12.82
Open 12.64
Previous Close 12.77 12.77
Volume 120,424 120,424
Avg Vol 393,980 393,980
Stochastic %K 25.52% 25.52%
Weighted Alpha -66.74 -66.74
5-Day Change -1.24 (-9.25%) -1.24 (-9.25%)
52-Week Range 11.60 - 45.00 11.60 - 45.00
  • 1D
  • 5D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
  • MAX
Full Chart
  • OHLC Bars
  • Colored OHLC Bars
  • HLC Bars
  • Candlestick Hollow
  • Candlestick Open-to-Close
  • Candlestick Close-to-Close
  • Heikin-Ashi
  • Line Chart
  • Area Chart
  • Renko
  • Column
  • Baseline
  • Line Break
  • Range
  • Kagi
  • Point And Figure
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 346,322
  • Shares Outstanding, K 27,120
  • Annual Sales, $ 152,310 K
  • Annual Income, $ -80,940 K
  • EBIT $ -96 M
  • EBITDA $ -92 M
  • 60-Month Beta 2.96
  • Price/Sales 2.36
  • Price/Cash Flow N/A
  • Price/Book 1.49

Options Overview Details

View History
  • Implied Volatility 89.70% ( +4.07%)
  • Historical Volatility 69.14%
  • IV Percentile 83%
  • IV Rank 57.46%
  • IV High 129.75% on 03/06/25
  • IV Low 35.61% on 08/21/24
  • Put/Call Vol Ratio 0.20
  • Today's Volume 78
  • Volume Avg (30-Day) 225
  • Put/Call OI Ratio 0.39
  • Today's Open Interest 5,100
  • Open Int (30-Day) 8,224

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 03/31/25
See More
  • Average Estimate -1.10
  • Number of Estimates 3
  • High Estimate 0.20
  • Low Estimate -2.10
  • Prior Year -1.00
  • Growth Rate Est. (year over year) -10.00%

Price Performance

See More
Period Period Low Period High Performance
1-Month
11.60 +4.83%
on 03/21/25
Period Open: 16.58
17.32 -29.79%
on 03/03/25
-4.42 (-26.66%)
since 02/26/25
3-Month
11.60 +4.83%
on 03/21/25
Period Open: 16.93
21.26 -42.80%
on 01/07/25
-4.77 (-28.17%)
since 12/26/24
52-Week
11.60 +4.83%
on 03/21/25
Period Open: 32.13
45.00 -72.98%
on 06/05/24
-19.97 (-62.15%)
since 03/26/24

Most Recent Stories

More News
2 Growth Stocks to Buy Now With 367% to 410% Upside

Strong, innovative pipelines make these two biotech firms smart buys now.

$SPX : 5,723.09 (-0.93%)
ARCT : 12.07 (-5.48%)
PHAT : 6.32 (-1.10%)
Arcturus Therapeutics: Q4 Earnings Snapshot

Arcturus Therapeutics: Q4 Earnings Snapshot

ARCT : 12.07 (-5.48%)
New Vaccine Technologies Lead the Charge as Global Immunization Efforts Evolve

Issued on behalf of BioVaxys Technology Corp. VANCOUVER – USA News Group – According to the World Health...

PCVX : 69.68 (-3.09%)
BVAXF : 0.0390 (+2.90%)
BIOV.CN : 0.0550 (unch)
GILD : 109.38 (+1.38%)
GOVX : 1.3750 (+0.36%)
ARCT : 12.07 (-5.48%)
Arcturus Therapeutics: Q3 Earnings Snapshot

Arcturus Therapeutics: Q3 Earnings Snapshot

ARCT : 12.07 (-5.48%)
New Strong Buy Stocks for September 13th

Here are five stocks added to the Zacks Rank #1 (Strong Buy) List today:Arcturus Therapeutics Holdings Inc. ARCT: This biotechnology company has seen the Zacks Consensus Estimate for its current year earnings...

ANGO : 9.99 (-1.87%)
PAM : 82.45 (-1.93%)
ARCT : 12.07 (-5.48%)
MHO : 118.01 (+0.18%)
FMBH : 35.68 (+0.68%)
Arcturus Therapeutics: Q2 Earnings Snapshot

Arcturus Therapeutics: Q2 Earnings Snapshot

ARCT : 12.07 (-5.48%)
Stocks See Support from Chip Stocks But T-Note Yield Rises

The S&P 500 Index ($SPX ) (SPY ) Tuesday closed up +0.02%, the Dow Jones Industrials Index ($DOWI ) (DIA ) closed down -0.55%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed up +0.32%. US stock indexes...

$SPX : 5,723.09 (-0.93%)
SPY : 569.73 (-1.00%)
$DOWI : 42,494.79 (-0.22%)
DIA : 424.88 (-0.22%)
$IUXX : 19,963.25 (-1.60%)
QQQ : 485.20 (-1.67%)
ZNM25 : 110-170 (-0.20%)
MRNA : 31.82 (-6.00%)
ZS : 212.09 (-1.69%)
PNR : 90.61 (-0.65%)
LULU : 335.50 (-0.55%)
PEP : 148.37 (+1.94%)
Stocks Mixed in TodayAfternoon Trade

The S&P 500 Index ($SPX ) (SPY ) today is down -0.14%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.72%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.39%. US stock indexes today are...

$SPX : 5,723.09 (-0.93%)
SPY : 569.73 (-1.00%)
$DOWI : 42,494.79 (-0.22%)
DIA : 424.88 (-0.22%)
$IUXX : 19,963.25 (-1.60%)
QQQ : 485.20 (-1.67%)
ZNM25 : 110-170 (-0.20%)
NVDA : 113.56 (-5.91%)
MU : 91.25 (-3.11%)
ASML : 705.39 (-2.94%)
AMD : 109.60 (-4.54%)
QCOM : 157.66 (-1.55%)
Stocks See Mild Pressure from Hawkish Fed Comments

The S&P 500 Index ($SPX ) (SPY ) today is down -0.04%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is down -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.07%. US stock indexes today are...

$SPX : 5,723.09 (-0.93%)
SPY : 569.73 (-1.00%)
$DOWI : 42,494.79 (-0.22%)
DIA : 424.88 (-0.22%)
$IUXX : 19,963.25 (-1.60%)
QQQ : 485.20 (-1.67%)
ZNM25 : 110-170 (-0.20%)
AAPL : 222.50 (-0.56%)
NVDA : 113.56 (-5.91%)
MU : 91.25 (-3.11%)
ASML : 705.39 (-2.94%)
AMD : 109.60 (-4.54%)
Why Shares of Arcturus Therapeutics Dropped on Tuesday

The company saw revenue decline and net losses rise in the second quarter.

ARCT : 12.07 (-5.48%)

Business Summary

Arcturus Therapeutics Ltd. is a preclinical-stage biopharmaceutical company. It focuses on the discovery, development and commercialization of RNA medicines using proprietary lipid-mediated delivery system LUNAR(TM) and UNA Oligomer chemistry technologies. Arcturus Therapeutics Ltd, formerly known as...

See More

Key Turning Points

3rd Resistance Point 14.00
2nd Resistance Point 13.70
1st Resistance Point 13.24
Last Price 12.07
1st Support Level 12.48
2nd Support Level 12.18
3rd Support Level 11.71

See More

52-Week High 45.00
Fibonacci 61.8% 32.24
Fibonacci 50% 28.30
Fibonacci 38.2% 24.36
Last Price 12.07
52-Week Low 11.60

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar
Precision Trading with Bollinger Bands: Identifying Breakouts & Reversals